2,000 Shares in UiPath Inc. (NYSE:PATH) Bought by Future Financial Wealth Managment LLC

Future Financial Wealth Managment LLC acquired a new position in shares of UiPath Inc. (NYSE:PATH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,000 shares of the healthcare company’s stock, valued at approximately $26,000.

A number of other institutional investors have also made changes to their positions in the stock. Green Alpha Advisors LLC grew its stake in shares of UiPath by 14.4% during the third quarter. Green Alpha Advisors LLC now owns 33,674 shares of the healthcare company’s stock worth $431,000 after purchasing an additional 4,226 shares during the period. SG Americas Securities LLC grew its stake in shares of UiPath by 220.8% during the third quarter. SG Americas Securities LLC now owns 134,629 shares of the healthcare company’s stock worth $1,723,000 after purchasing an additional 92,659 shares during the period. Sanctuary Advisors LLC bought a new position in UiPath during the second quarter worth about $155,000. Advisory Alpha LLC bought a new position in UiPath during the second quarter worth about $131,000. Finally, Capital Impact Advisors LLC lifted its holdings in UiPath by 162.9% during the second quarter. Capital Impact Advisors LLC now owns 36,400 shares of the healthcare company’s stock worth $462,000 after acquiring an additional 22,553 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at $10,258,498.19. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 22.37% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

PATH has been the topic of several recent analyst reports. Wells Fargo & Company lifted their target price on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Friday, September 6th. Evercore ISI lifted their target price on UiPath from $13.00 to $16.00 and gave the stock an “in-line” rating in a report on Friday, September 6th. Morgan Stanley reiterated an “equal weight” rating and set a $15.00 target price on shares of UiPath in a report on Friday, September 6th. TD Cowen cut their price target on UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, September 6th. Finally, DA Davidson boosted their price target on UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $17.71.

UiPath Stock Up 1.0 %

Shares of NYSE PATH opened at $12.56 on Friday. The business’s 50 day moving average price is $12.20 and its two-hundred day moving average price is $14.87. The company has a market cap of $7.19 billion, a PE ratio of -78.50 and a beta of 0.88. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87.

UiPath (NYSE:PATH) last posted its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The company had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. During the same quarter in the prior year, the business earned ($0.09) earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. As a group, research analysts anticipate that UiPath Inc. will post -0.23 EPS for the current fiscal year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.